| Overall (n = 297) | ET-IGN group (n = 246) | EUT-IGN group (n = 51) | p†|
---|---|---|---|---|
Age, mean ± SD (yr) | 59.4 ± 9.1 | 60.3 ± 9.0 | 55.0 ± 8.5 | < 0.001 |
Male sex (%) | 226 (76.1) | 196 (79.7) | 30 (58.8) | 0.001 |
BMI, median (IQR) (kg/m2) | 24.4 (22.4–26.0) | 24.6 (22.6–26.0) | 23.5 (21.3–25.8) | 0.030 |
Previous diagnosis with other cancer (%) | 37 (12.5) | 31 (12.5) | 6 (11.8) | 0.869 |
Family history of gastric cancer (%) | 67 (22.6) | 53 (21.5) | 14 (27.5) | 0.358 |
H. pylori infection‡ (%) | 212/296 (71.6) | 170/245 (69.4) | 42/51 (82.4) | 0.062 |
Current or ex-smoker (%) | 196 (66.0) | 171 (69.5) | 25 (49.0) | 0.005 |
Previous abnormality at the same location (%) | 31 (10.4) | 24 (9.8) | 7 (13.7) | 0.399 |
Gastric atrophy, Kimura-Takemoto classification (%) | Â | Â | Â | 0.002 |
 Absent (C0) | 12 (4.0) | 7 (2.8) | 5 (9.8) |  |
 Mild (C1, C2) | 54 (18.2) | 38 (15.4) | 16 (31.4) |  |
 Moderate (C3, O1) | 165 (55.6) | 141 (57.3) | 24 (47.1) |  |
 Severe (O2, O3) | 66 (22.2) | 60 (24.4) | 6 (11.8) |  |
Intestinal metaplasia§ (%) | 175 (58.9) | 156 (63.4) | 19 (37.3) | 0.001 |
Interval since last upper GI endoscopy, median (IQR) (months) | 12.0 (11.0–15.0) | 12.0 (11.0–15.0) | 12.0 (11.0–14.0) | 0.847 |